Literature DB >> 11170903

Founder mutations of BRCA1 and BRCA2 in North American families of Polish origin that are affected with breast cancer.

P de los Rios, E Jack, G Kuperstein, H Lynch, J Lubinski, S A Narod.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11170903      PMCID： PMC1235292          DOI： 10.1086/318211

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN： 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  3 in total

1.  Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes?

Authors:  O M Serova; S Mazoyer; N Puget; V Dubois; P Tonin; Y Y Shugart; D Goldgar; S A Narod; H T Lynch; G M Lenoir
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

2.  Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia.

Authors:  S A Gayther; P Harrington; P Russell; G Kharkevich; R F Garkavtseva; B A Ponder
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

3.  Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer.

Authors:  B Górski; T Byrski; T Huzarski; A Jakubowska; J Menkiszak; J Gronwald; A Pluzańska; M Bebenek; L Fischer-Maliszewska; E Grzybowska; S A Narod; J Lubiński
Journal:  Am J Hum Genet       Date:  2000-04-28       Impact factor: 11.025
  3 in total
  3 in total

1.  The D13S171 marker, misannotated to BRCA2, links the AS3 gene to various cancers.

Authors:  P Geck; C Sonnenschein; A M Soto
Journal:  Am J Hum Genet       Date:  2001-08       Impact factor: 11.025

2.  Identification of the prevalent BRCA1 and BRCA2 mutations in the female population of Puerto Rico.

Authors:  Julie Dutil; Jose L Colon-Colon; Jaime L Matta; Rebecca Sutphen; Miguel Echenique
Journal:  Cancer Genet       Date:  2012-05

3.  Selected Aspects of Molecular Diagnostics of Constitutional Alterations in BRCA1 and BRCA2 Genes Associated with Increased Risk of Breast Cancer in the Polish Population.

Authors:  Bohdan Górski
Journal:  Hered Cancer Clin Pract       Date:  2006-08-15       Impact factor: 2.857
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.